Financials Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-02-28 pm EST 5-day change 1st Jan Change
179,700 KRW -5.42% Intraday chart for Celltrion, Inc. +1.81% -10.82%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 28,333,774 24,175,552 48,989,351 27,592,583 23,000,359 37,819,266 37,819,266 -
Enterprise Value (EV) 2 28,318 24,047 49,090 27,117 23,236 27,970 37,819 37,819
P/E ratio 107 x 77.7 x 94.4 x 47.2 x 41.6 x 37.1 x 45.9 x 26.8 x
Yield 0.01% - - 0.38% - 0.21% 0.21% 0.23%
Capitalization / Revenue 28.9 x 21.4 x 26.5 x 14.6 x 10.1 x 12.9 x 11.3 x 9.15 x
EV / Revenue 28.8 x 21.3 x 26.5 x 14.3 x 10.2 x 12.9 x 11.3 x 9.15 x
EV / EBITDA 60.8 x 44.8 x 55.1 x 27.9 x 26.6 x 36.5 x 32.4 x 21.2 x
EV / FCF 93.6 x 63.3 x 186 x 46 x -211 x 58.6 x 66.7 x 33.5 x
FCF Yield 1.07% 1.58% 0.54% 2.17% -0.47% 1.71% 1.5% 2.98%
Price to Book 11 x 8.27 x 14.4 x 6.87 x 5.34 x 5.64 x 6.15 x 5.41 x
Nbr of stocks (in thousands) 144,676 144,521 144,757 144,931 143,304 210,458 210,458 -
Reference price 3 195,843 167,280 338,424 190,385 160,500 179,700 179,700 179,700
Announcement Date 2/25/19 2/19/20 2/22/21 2/16/22 3/3/23 2/29/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 982.1 1,128 1,849 1,891 2,284 2,176 3,352 4,131
EBITDA 1 465.5 537.3 891.4 972.1 873.6 1,024 1,166 1,787
EBIT 1 338.7 378.1 712.1 753.9 647.2 651.5 858 1,518
Operating Margin 34.49% 33.5% 38.51% 39.87% 28.34% 29.93% 25.6% 36.73%
Earnings before Tax (EBT) 1 317.7 378.6 650.7 746.9 626.2 671.1 1,134 1,931
Net income 1 261.8 297.6 511.3 575.1 533.2 535.6 856 1,458
Net margin 26.66% 26.37% 27.65% 30.42% 23.34% 24.61% 25.54% 35.29%
EPS 2 1,833 2,153 3,586 4,031 3,855 4,850 3,919 6,707
Free Cash Flow 3 302,664 379,716 263,739 589,594 -110,305 638,320 567,000 1,128,000
FCF margin 30,818.8% 33,649.04% 14,262.95% 31,181.9% -4,829.54% 26,950.31% 16,916.35% 27,303.61%
FCF Conversion (EBITDA) 65,024.51% 70,673.9% 29,586.45% 60,648.72% - 62,324.28% 48,623.02% 63,105.09%
FCF Conversion (Net income) 115,590.22% 127,593.57% 51,582.76% 102,521.45% - 90,791.68% 66,238.32% 77,366.26%
Dividend per Share 2 17.60 - - 721.2 - 372.5 380.2 414.8
Announcement Date 2/25/19 2/19/20 2/22/21 2/16/22 3/3/23 2/29/24 - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 431.8 401 601.1 550.6 596.1 645.6 510.6 597.5 524 672.3 382.6 754.1 856.9 905.9 997.1
EBITDA - - - - - - - - - - - - - - -
EBIT 1 163.2 164 219 142.3 199 213.8 100.6 182.4 183 267.6 18.42 113 207.6 275.3 365.5
Operating Margin 37.8% 40.9% 36.43% 25.84% 33.38% 33.11% 19.71% 30.52% 34.92% 39.81% 4.82% 14.98% 24.22% 30.39% 36.65%
Earnings before Tax (EBT) 155.6 187.6 145.2 - 226.8 217.3 48.49 208.2 189.7 282.9 - - - - -
Net income 1 125.5 135.5 120.5 118.5 183.4 166.7 64.53 166.9 147.5 221.8 1.054 130 163 242 322
Net margin 29.07% 33.79% 20.04% 21.53% 30.77% 25.82% 12.64% 27.93% 28.15% 33% 0.28% 17.24% 19.02% 26.71% 32.29%
EPS - - - - - 1,162 470.0 1,155 1,034 1,561 - - - - -
Dividend per Share 2 - - - - - - - - - - 300.0 - - - 200.0
Announcement Date 8/13/21 11/10/21 2/16/22 5/12/22 8/5/22 11/9/22 3/3/23 5/8/23 8/14/23 11/7/23 2/29/24 - - - -
1KRW in Billions2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - 100 - 236 - - -
Net Cash position 1 15.5 128 - 476 - 443 - -
Leverage (Debt/EBITDA) - - 0.1126 x - 0.2696 x - - -
Free Cash Flow 2 302,664 379,716 263,739 589,594 -110,305 638,320 567,000 1,128,000
ROE (net income / shareholders' equity) 10.8% 11.2% 16.7% 16.5% 12.9% 13.9% 9.46% 13%
ROA (Net income/ Total Assets) 7.64% 8.02% 11.6% 10.7% 9.22% 11.1% - -
Assets 1 3,428 3,713 4,402 5,372 5,783 6,357 - -
Book Value Per Share 3 17,819 20,218 23,501 27,732 30,040 31,875 29,211 33,210
Cash Flow per Share 3 2,697 3,430 2,460 6,417 6.250 7,402 6,885 7,437
Capex 1 79.4 94.3 87 63.4 111 95.7 - -
Capex / Sales 8.09% 8.35% 4.71% 3.35% 4.87% 4.04% - -
Announcement Date 2/25/19 2/19/20 2/22/21 2/16/22 3/3/23 2/29/24 - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
179,700 KRW
Average target price
218,688 KRW
Spread / Average Target
+21.70%
Consensus
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW